Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiofrequency Ablation for Aldosterone-producting Adenoma in Patients With Primary Aldosteronism: Evaluation of the Blood Pressure Control and of Its Safety.

NCT02756754 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT02756754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02756754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiofrequency Ablation for Aldosterone-producting Adenoma in Patients With Primary Aldosteronism: Evaluation of the Blood Pressure Control and of Its Safety.
Lead sponsor
University Hospital, Toulouse
Phase
Not applicable
Overall status
Completed
Start date
November 7, 2016
Completion date
May 10, 2019
Enrollment
31 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adrenal adenoma, primary aldosteronism